1Pui CH, Relling MV, Sandlund JT, et al. Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. AnnHematol, 2004;83 :S124-S126.
2Rajajee S, Desikulu MV, Pushpa V, et al. Survival of childhood acute lymphoblastic leukemia: experience in Chennai. J Trop Pediatr, 1999 ;45:367-370.
3Pul CH, Relling MV, Downing JR, et al. Acute lymphoblastic leukemia. N Engl J Med, 2004 ;350 : 1535-1548.
4Charles G. Mullighan, Salil Goorha, Ina Radtke, et al. Genomewide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature, 2007 ;446:758-764.
5Mary E. Ross, Xiaodong Zhou, Guangchun Song, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood, 2003 ;102:2951-2959.
6Pui CH, Sallan S, Relling MV, et al. International Childhood Acute Lymphoblastic Leukemia Workshop : Sausalito, CA, 30 November -Ⅰ December 2000. Leukemia, 2001 ;15:707-715.
7Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St. Jude Children' s Research Hospital. Blood, 2004;104: 2690-2696.
8Goldberg JM, Silverman LB, Levy DE, et al. Childhood T-cell acute lymphoblastic leukemia: the Dana- Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol, 2003; 21:3616-3622.
9Pui CH, Sandlund JT, Pei D. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA, 2003; 290:2001-2007.
10Gunnar Cario, Martin Stanulla, Bernard M, et al. Fine, et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood, 2005; 105:821-826.
